Researchers find genome sequencing can be used to identify severe intellectual disability

June 5, 2014 by Bob Yirka report
Researchers find genome sequencing can be used to identify severe intellectual disability

(Medical Xpress)—A large team of researchers based in the Netherlands has found that whole genome sequencing can be used to identify a large percentage of patients who have a severe intellectual disability (SID). In their paper published in the journal Nature, the team describes how they took a new approach when analyzing gene sequences of SID patients and found that a pattern of genetic abnormalities could be used to diagnose the disorder with an accuracy of 62 percent.

People with a SID (formerly described as various types of severe mental retardation) typically have a very low IQ and associated difficulties in developing both cognitive and functional skills. As medical science has progressed, parents and doctors have been presented with more and more tools for diagnosing various ailments with babies both before and after birth. A diagnosis of SID, however, has been elusive, often only being recognized when a child reaches an age where cognitive skills become apparent. In this new effort, the researchers describe a new type of whole genome sequencing analysis that they claim can be used to diagnose SID in a large number of cases.

SID is unique in that the condition generally comes about due to genetic abnormalities that are not inherited—something happens after conception to alter the genome. Because of this, testing parents for SID risk in offspring is futile. In this new effort, the researchers obtained DNA samples from 50 people who had the condition, and from their parents. They performed whole genome sequencing on all of the samples and then compared the results of each with all the others and with the number of copies of each gene. Doing so revealed 84 previously unknown sequence variations and eight copy number variations. Many of the variations, the researchers found, were mutations that caused genes to stop functioning.

Using what they'd learned, the team turned the results around and applied them as a diagnostic aid—they found that they were able to identify 21 of the original 50 patients as having SID. That means, they claim, that going forward, whole genome sequencing can be used to identify SID with 62 percent accuracy. The data also adds further proof that the majority of cases of SID are the result of non-inherited genetic anomalies, which means research going forward, can focus on the underlying cause of the gene anomalies, rather than continuing to search for something in the parents' genes.

Explore further: Uncovering clues to the genetic cause of schizophrenia

More information: Genome sequencing identifies major causes of severe intellectual disability, Nature (2014) doi:10.1038/nature13394

Severe intellectual disability (ID) occurs in 0.5% of newborns and is thought to be largely genetic in origin. The extensive genetic heterogeneity of this disorder requires a genome-wide detection of all types of genetic variation. Microarray studies and, more recently, exome sequencing have demonstrated the importance of de novo copy number variations (CNVs) and single-nucleotide variations (SNVs) in ID, but the majority of cases remain undiagnosed. Here we applied whole-genome sequencing to 50 patients with severe ID and their unaffected parents. All patients included had not received a molecular diagnosis after extensive genetic prescreening, including microarray-based CNV studies and exome sequencing. Notwithstanding this prescreening, 84 de novo SNVs affecting the coding region were identified, which showed a statistically significant enrichment of loss-of-function mutations as well as an enrichment for genes previously implicated in ID-related disorders. In addition, we identified eight de novo CNVs, including single-exon and intra-exonic deletions, as well as interchromosomal duplications. These CNVs affected known ID genes more frequently than expected. On the basis of diagnostic interpretation of all de novo variants, a conclusive genetic diagnosis was reached in 20 patients. Together with one compound heterozygous CNV causing disease in a recessive mode, this results in a diagnostic yield of 42% in this extensively studied cohort, and 62% as a cumulative estimate in an unselected cohort. These results suggest that de novo SNVs and CNVs affecting the coding region are a major cause of severe ID. Genome sequencing can be applied as a single genetic test to reliably identify and characterize the comprehensive spectrum of genetic variation, providing a genetic diagnosis in the majority of patients with severe ID.

Press release

Related Stories

Uncovering clues to the genetic cause of schizophrenia

May 28, 2014

The overall number and nature of mutations—rather than the presence of any single mutation—influences an individual's risk of developing schizophrenia, as well as its severity, according to a discovery by Columbia University ...

A new syndrome caused by mutations in AHDC1

May 1, 2014

A team of researchers led by Baylor College of Medicine have identified the gene underlying a newly recognized genetic syndrome that has symptoms of sleep apnea, delayed speech and hyptonia, or generalized upper body weakness.

Recommended for you

New insights on triggering muscle formation

April 26, 2017

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a previously unrecognized step in stem cell-mediated muscle regeneration. The study, published in Genes and Development, provides new ...

Risk of obesity influenced by changes in our genes

April 25, 2017

These changes, known as epigenetic modifications, control the activity of our genes without changing the actual DNA sequence. One of the main epigenetic modifications is DNA methylation, which plays a key role in embryonic ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Jun 05, 2014
Quick! Administer this test to everyone in congress! Never mind, we already know the results...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.